Evaluation of animal models of neurobehavioral disorders
Open accessThe DOI matches its Crossref record; 203 of the 203 references it cites were found in a registry or an index.
Abstract
Animal models play a central role in all areas of biomedical research. The process of animal model building, development and evaluation has rarely been addressed systematically, despite the long history of using animal models in the investigation of neuropsychiatric disorders and behavioral dysfunctions. An iterative, multi-stage trajectory for developing animal models and assessing their quality is proposed. The process starts with defining the purpose(s) of the model, preferentially based on hypotheses about brain-behavior relationships. Then, the model is developed and tested. The evaluation of the model takes scientific and ethical criteria into consideration. Model development requires a multidisciplinary approach. Preclinical and clinical experts should establish a set of scientific criteria, which a model must meet. The scientific evaluation consists of assessing the replicability/reliability, predictive, construct and external validity/generalizability, and relevance of the model. We emphasize the role of (systematic and extended) replications in the course of the validation process. One may apply a multiple-tiered 'replication battery' to estimate the reliability/replicability, validity, and generalizability of result. Compromised welfare is inherent in many deficiency models in animals. Unfortunately, 'animal welfare' is a vaguely defined concept, making it difficult to establish exact evaluation criteria. Weighing the animal's welfare and considerations as to whether action is indicated to reduce the discomfort must accompany the scientific evaluation at any stage of the model building and evaluation process. Animal model building should be discontinued if the model does not meet the preset scientific criteria, or when animal welfare is severely compromised. The application of the evaluation procedure is exemplified using the rat with neonatal hippocampal lesion as a proposed model of schizophrenia. In a manner congruent to that for improving animal models, guided by the procedure expounded upon in this paper, the developmental and evaluation procedure itself may be improved by careful definition of the purpose(s) of a model and by defining better evaluation criteria, based on the proposed use of the model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–203 of 203
Researchers Pained by Effort to Define Distress Precisely
Holden, C. (2000) · Science · doi:10.1126/science.290.5496.1474 · Cited by 9
Johnson, D. K., Rinchik, E. M., Moustaïd‐Moussa, N., Miller, D. R., Williams, R. W., Michaud, E. J., Jablonski, M. M., Elberger, A. J., Hamre, K., Smeyne, R. J., et al. (2005) · AGE · doi:10.1007/s11357-005-4131-3 · Cited by 6
Health-promoting factors and animal welfare.
Terranova, M. L., & Laviola, G. (2004) · PubMed · Cited by 4
Cited by
Belzung, C., & Lemoine, M. (2011) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-1-9 · Cited by 438
Reproducibility of animal research in light of biological variation
Voelkl, B., Altman, N. S., Forsman, A., Forstmeier, W., Gurevitch, J., Jaric, I., Karp, N. A., Kas, M. J., Schielzeth, H., Van de Casteele, T., et al. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0313-3 · Cited by 390
Epidemiology-driven neurodevelopmental animal models of schizophrenia
Meyer, U., & Feldon, J. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.10.018 · Cited by 372
Gribkoff, V. K., & Kaczmarek, L. K. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.021 · Cited by 371
3D Bioprinting of Tissue/Organ Models
Pati, F., Gantelius, J., & Svahn, H. A. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201505062 · Cited by 301
Metadata
- Authors
- van der Staay, F. J., Arndt, S. S., & Nordquist, R. E.
- Venue
- Behavioral and Brain Functions
- Published
- 2009-02-25
- Volume
- 5
- Issue
- 1
- Pages
- 11-11
- ISSN
- 1744-9081 (ISSN-L)
- OpenAlex
- W2132058857
- Cited by
- 296
- References
- 203
- FWCI
- 22.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.